Activation of mitochondrial ATP‐sensitive potassium channels increases cell viability against rotenone‐induced cell death
暂无分享,去创建一个
[1] E. Rojas,et al. Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. , 2000, European journal of pharmacology.
[2] C. Culmsee,et al. Neuronal apoptosis in Alzheimer ’ s disease , 2001 .
[3] Yongge Liu,et al. Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels. , 1999, Molecular pharmacology.
[4] Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Lazdunski,et al. Galanin inhibits dopamine secretion and activates a potassium channel in pheochromocytoma cells , 1989, Brain Research.
[6] INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .
[7] K. Mikoshiba,et al. ‘Ischemic tolerance’ phenomenon found in the brain , 1990, Brain Research.
[8] G. Grover,et al. Role of Myocardial ATP‐Sensitive Potassium Channels in Mediating Preconditioning in the Dog Heart and Their Possible Interaction With Adenosine A1‐Receptors , 1992, Circulation.
[9] R. Houghten,et al. An N-methyl-d-aspartate receptor channel blocker with neuroprotective activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Szewczyk,et al. The mitochondrial sulfonylurea receptor: identification and characterization. , 1997, Biochemical and biophysical research communications.
[11] E. Marbán,et al. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. , 2000, Circulation.
[12] F. Ashcroft,et al. Metabolic inhibition and low internal ATP activate K-ATP channels in rat dopaminergic substantia nigra neurones , 1995, Pflügers Archiv.
[13] D. Truong,et al. Activation of adenosine triphosphate‐sensitive potassium channels confers protection against rotenone‐induced cell death: Therapeutic implications for Parkinson's disease , 2002, Journal of neuroscience research.
[14] E. Nevo,et al. Reciprocal regulation of expression of pore‐forming KATP channel genes by hypoxia , 2001, Molecular and Cellular Biochemistry.
[15] F. Ashcroft,et al. Properties and functions of ATP-sensitive K-channels. , 1990, Cellular signalling.
[16] G. Grover. Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. , 1997, Canadian journal of physiology and pharmacology.
[17] K. Kunjilwar,et al. Association and Stoichiometry of KATP Channel Subunits , 1997, Neuron.
[18] A. Terzic,et al. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. , 1998, American journal of physiology. Heart and circulatory physiology.
[19] M. Smith,et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.
[20] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[21] K. Tai,et al. Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. , 1991, Journal of molecular and cellular cardiology.
[22] M. Mattson,et al. Activation of Mitochondrial ATP-Dependent Potassium Channels Protects Neurons against Ischemia-Induced Death by a Mechanism Involving Suppression of Bax Translocation and Cytochrome c Release , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] S. Seino,et al. Kir6.1: a possible subunit of ATP-sensitive K+ channels in mitochondria. , 1997, Biochemical and biophysical research communications.
[24] V. Kupriyanov,et al. Effects of KATP Channel Openers, P-1075, Pinacidil, and Diazoxide, on Energetics and Contractile Function in Isolated Rat Hearts , 2002 .
[25] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[26] E. Marbán,et al. Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. , 2000, Circulation.
[27] Yongge Liu,et al. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. , 2001, Molecular pharmacology.
[28] V. Kupriyanov,et al. Effects of K(ATP) channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts. , 2002, Journal of molecular and cellular cardiology.
[29] David Y. Thomas,et al. Localization of Endogenous Grb10 to the Mitochondria and Its Interaction with the Mitochondrial-associated Raf-1 Pool* , 1999, The Journal of Biological Chemistry.
[30] G. Grover,et al. Cardioprotection with the KATP Opener Cromakalim Is Not Correlated with Ischemic Myocardial Action Potential Duration , 1995, Journal of cardiovascular pharmacology.
[31] A. Kowaltowski,et al. Identification and Properties of a Novel Intracellular (Mitochondrial) ATP-sensitive Potassium Channel in Brain* , 2001, The Journal of Biological Chemistry.